Insider media online6 Aug 2020 08:40
York-based medical device manufacturer Abingdon Health has received a key approval for its Covid-19 rapid antibody test.
The company, which is leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark, meaning the test is approved for professional use in the UK and EU.
Following the approval, the rapid test, for detection of IgG antibodies to the SARS-CoV-2 virus (Covid-19), is now available for distribution for professional use. It is now set to be mass produced, with tests to be rolled out from the end of August 2020.
Abingdon Health is aiming to produce 500,000 Covid-19 antibody tests a month from October and one million a month from January 2021.